Alexandre Marchand
Overview
Explore the profile of Alexandre Marchand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Collomp K, Teulier C, Castanier C, Bonnigal J, Marchand A, Buisson C, et al.
Drug Test Anal
. 2025 Feb;
PMID: 39911023
Haematological and inflammatory biomarkers play an important role in athlete performance and health, with some of them used in the fight against doping. However, little is known about how they...
2.
Loup B, Andre F, Leuenberger N, Marchand A, Barnabe A, Delcourt V, et al.
Drug Test Anal
. 2024 Sep;
PMID: 39321850
Detection and monitoring of biomarkers related to doping is particularly suitable for the development of analytical strategies dedicated to indirect detection of banned substances. Previous studies in horses have already...
3.
Maaziz N, Martin L, Marchand A, Gardie B, Girodon F
J Intern Med
. 2024 Jul;
296(2):213-214.
PMID: 38982591
No abstract available.
4.
Marchand A, Ericsson M
Drug Test Anal
. 2024 Feb;
16(12):1479-1486.
PMID: 38403885
Homologous blood transfusion (HBT) is used for doping in endurance sports since the 1960s. The blood comes from a compatible donor, that is, someone with a compatible ABO and rhesus...
5.
Heiland C, Martin L, Zhou X, Zhang L, Ericsson M, Marchand A
Drug Test Anal
. 2023 Nov;
16(6):650-654.
PMID: 37942506
The abuse of recombinant erythropoietin (rEPO) and other erythropoietin (EPO) receptor agonists (ERAs) in sports prompted the need for sensitive detection methods of these substances. Dried blood spot (DBS) samples...
6.
Marchand A, Roulland I, Semence F, Jaffredo F, Dehainault C, Le Guiner S, et al.
Drug Test Anal
. 2023 Jan;
15(11-12):1417-1429.
PMID: 36709998
Two doping cases of homologous blood transfusion (HBT) during Tokyo 2020 Summer Olympics have shown that more controls are needed. The method of detection using flow cytometry to evaluate the...
7.
Fabre M, Mathieu B, Tiollier E, Leduc C, Clauss M, Marchand A, et al.
Nutrients
. 2022 Nov;
14(22).
PMID: 36432469
The importance of optimized recovery during a sport competition is undisputed. The objective of this study was to determine the effects of recovery drinks comprising either carbohydrate only, or a...
8.
Neyrinck-Leglantier D, Tamagne M, Lhonore S, Cagnet L, Pakdaman S, Marchand A, et al.
Front Immunol
. 2022 Sep;
13:992483.
PMID: 36172364
Extracellular vesicles (EVs), which are generated by cell membrane budding in diverse cells, are present in variable numbers in the blood. An immunoregulatory role has been demonstrated principally for heterologous...
9.
Marchand A, Miller G, Martin L, Gobbo C, Crouch A, Eichner D, et al.
Drug Test Anal
. 2022 Jul;
14(11-12):1952-1961.
PMID: 35789123
Luspatercept (Reblozyl®) is a newly approved anti-anemic drug prohibited by the World Anti-Doping Agency. It promotes erythropoiesis by limiting apoptosis of immature erythroblasts and the risk of misuse by athletes...
10.
Heiland C, Ericsson M, Pohanka A, Ekstrom L, Marchand A
Drug Test Anal
. 2022 Mar;
14(8):1377-1386.
PMID: 35322582
The World Anti-Doping Agency (WADA) has recently implemented dried blood spots (DBSs) as a matrix for doping control. However, specifications regarding the analysis of the class of prohibited substances called...